1,332
Participants
Start Date
February 17, 2009
Primary Completion Date
July 23, 2009
Study Completion Date
October 15, 2009
Boostrix®
Intramuscular, single dose.
Decavac™
Intramuscular, single dose.
GSK Investigational Site, Columbia
GSK Investigational Site, Elkridge
GSK Investigational Site, Williamsburg
GSK Investigational Site, High Point
GSK Investigational Site, Wilmington
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Stockbridge
GSK Investigational Site, DeLand
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Bristol
GSK Investigational Site, Lexington
GSK Investigational Site, Cleveland
GSK Investigational Site, Mogadore
GSK Investigational Site, Wadsworth
GSK Investigational Site, Indianapolis
GSK Investigational Site, Stevensville
GSK Investigational Site, Pratt
GSK Investigational Site, Metairie
GSK Investigational Site, Fort Worth
GSK Investigational Site, West Jordan
GSK Investigational Site, Tucson
GSK Investigational Site, Los Angeles
GSK Investigational Site, Wenatchee
GSK Investigational Site, Milford
Lead Sponsor
GlaxoSmithKline
INDUSTRY